Skip to main content
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1998 Mar 15;26(6):1427–1432. doi: 10.1093/nar/26.6.1427

Temporally and spatially regulated somatic mutagenesis in mice.

F Schwenk 1, R Kuhn 1, P O Angrand 1, K Rajewsky 1, A F Stewart 1
PMCID: PMC147429  PMID: 9490788

Abstract

In mice transgenesis through oocyte injection or DNA recombination in embryonal stem (ES) cells allows mutations to be introduced into the germline. However, the earliest phenotype of the introduced mutation can eclipse later effects. We show in mice that site-specific genomic recombination can be induced in a selected cell type, B lymphocytes, at a chosen time. This precision of somatic mutagenesis was accomplished by limiting expression of a Cre recombinase-estrogen receptor fusion protein to B lymphocytes by use of tissue-specific elements in the promoter of the transgene employed. The expressed fusion protein remained inactive until derepressed by systemic administration of an exogenous ligand for the estrogen receptor, 4-OH-tamoxifen. Upon derepression the Cre recombinase enzyme deleted specific DNA segments, flanked by loxP sites, in B lymphocytes only. The efficiency of recombination in cells expressing the fusion protein could be varied from low levels to >80%, depending on the dose of ligand administered. Our work presents a paradigm applicable to other uses of site-specific recombination in somatic mutagenesis where both temporal and spatial regulation are desired.

Full Text

The Full Text of this article is available as a PDF (185.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bedell M. A., Jenkins N. A., Copeland N. G. Mouse models of human disease. Part I: techniques and resources for genetic analysis in mice. Genes Dev. 1997 Jan 1;11(1):1–10. doi: 10.1101/gad.11.1.1. [DOI] [PubMed] [Google Scholar]
  2. Danielian P. S., White R., Hoare S. A., Fawell S. E., Parker M. G. Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol Endocrinol. 1993 Feb;7(2):232–240. doi: 10.1210/mend.7.2.8469236. [DOI] [PubMed] [Google Scholar]
  3. Feil R., Brocard J., Mascrez B., LeMeur M., Metzger D., Chambon P. Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10887–10890. doi: 10.1073/pnas.93.20.10887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gu H., Marth J. D., Orban P. C., Mossmann H., Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science. 1994 Jul 1;265(5168):103–106. doi: 10.1126/science.8016642. [DOI] [PubMed] [Google Scholar]
  5. Hennet T., Hagen F. K., Tabak L. A., Marth J. D. T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl-transferase gene by site-directed recombination. Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12070–12074. doi: 10.1073/pnas.92.26.12070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kellendonk C., Tronche F., Monaghan A. P., Angrand P. O., Stewart F., Schütz G. Regulation of Cre recombinase activity by the synthetic steroid RU 486. Nucleic Acids Res. 1996 Apr 15;24(8):1404–1411. doi: 10.1093/nar/24.8.1404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kilby N. J., Snaith M. R., Murray J. A. Site-specific recombinases: tools for genome engineering. Trends Genet. 1993 Dec;9(12):413–421. doi: 10.1016/0168-9525(93)90104-p. [DOI] [PubMed] [Google Scholar]
  8. Kühn R., Schwenk F., Aguet M., Rajewsky K. Inducible gene targeting in mice. Science. 1995 Sep 8;269(5229):1427–1429. doi: 10.1126/science.7660125. [DOI] [PubMed] [Google Scholar]
  9. Lakso M., Sauer B., Mosinger B., Jr, Lee E. J., Manning R. W., Yu S. H., Mulder K. L., Westphal H. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6232–6236. doi: 10.1073/pnas.89.14.6232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Littlewood T. D., Hancock D. C., Danielian P. S., Parker M. G., Evan G. I. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 1995 May 25;23(10):1686–1690. doi: 10.1093/nar/23.10.1686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lloyd A. M., Schena M., Walbot V., Davis R. W. Epidermal cell fate determination in Arabidopsis: patterns defined by a steroid-inducible regulator. Science. 1994 Oct 21;266(5184):436–439. doi: 10.1126/science.7939683. [DOI] [PubMed] [Google Scholar]
  12. Logie C., Stewart A. F. Ligand-regulated site-specific recombination. Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5940–5944. doi: 10.1073/pnas.92.13.5940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nichols M., Rientjes J. M., Logie C., Stewart A. F. FLP recombinase/estrogen receptor fusion proteins require the receptor D domain for responsiveness to antagonists, but not agonists. Mol Endocrinol. 1997 Jun;11(7):950–961. doi: 10.1210/mend.11.7.9944. [DOI] [PubMed] [Google Scholar]
  14. Picard D. Regulation of protein function through expression of chimaeric proteins. Curr Opin Biotechnol. 1994 Oct;5(5):511–515. doi: 10.1016/0958-1669(94)90066-3. [DOI] [PubMed] [Google Scholar]
  15. Picard D., Salser S. J., Yamamoto K. R. A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor. Cell. 1988 Sep 23;54(7):1073–1080. doi: 10.1016/0092-8674(88)90122-5. [DOI] [PubMed] [Google Scholar]
  16. Rickert R. C., Roes J., Rajewsky K. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 1997 Mar 15;25(6):1317–1318. doi: 10.1093/nar/25.6.1317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rosenbaum H., Webb E., Adams J. M., Cory S., Harris A. W. N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc. EMBO J. 1989 Mar;8(3):749–755. doi: 10.1002/j.1460-2075.1989.tb03435.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rossant J., Nagy A. Genome engineering: the new mouse genetics. Nat Med. 1995 Jun;1(6):592–594. doi: 10.1038/nm0695-592. [DOI] [PubMed] [Google Scholar]
  19. Sadek S., Bell S. C. The effects of the antihormones RU486 and tamoxifen on fetoplacental development and placental bed vascularisation in the rat: a model for intrauterine fetal growth retardation. Br J Obstet Gynaecol. 1996 Jul;103(7):630–641. doi: 10.1111/j.1471-0528.1996.tb09830.x. [DOI] [PubMed] [Google Scholar]
  20. Schwenk F., Sauer B., Kukoc N., Hoess R., Müller W., Kocks C., Kühn R., Rajewsky K. Generation of Cre recombinase-specific monoclonal antibodies, able to characterize the pattern of Cre expression in cre-transgenic mouse strains. J Immunol Methods. 1997 Sep 24;207(2):203–212. doi: 10.1016/s0022-1759(97)00116-6. [DOI] [PubMed] [Google Scholar]
  21. St-Onge L., Furth P. A., Gruss P. Temporal control of the Cre recombinase in transgenic mice by a tetracycline responsive promoter. Nucleic Acids Res. 1996 Oct 1;24(19):3875–3877. doi: 10.1093/nar/24.19.3875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Stancato L. F., Hutchison K. A., Krishna P., Pratt W. B. Animal and plant cell lysates share a conserved chaperone system that assembles the glucocorticoid receptor into a functional heterocomplex with hsp90. Biochemistry. 1996 Jan 16;35(2):554–561. doi: 10.1021/bi9511649. [DOI] [PubMed] [Google Scholar]
  23. Tsien J. Z., Chen D. F., Gerber D., Tom C., Mercer E. H., Anderson D. J., Mayford M., Kandel E. R., Tonegawa S. Subregion- and cell type-restricted gene knockout in mouse brain. Cell. 1996 Dec 27;87(7):1317–1326. doi: 10.1016/s0092-8674(00)81826-7. [DOI] [PubMed] [Google Scholar]
  24. Zhang Y., Riesterer C., Ayrall A. M., Sablitzky F., Littlewood T. D., Reth M. Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res. 1996 Feb 15;24(4):543–548. doi: 10.1093/nar/24.4.543. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES